Tumor-derived exosomes modulate PD-L1 expression in monocytes

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• Monocytes and macrophages in chronic lymphocytic leukemia (CLL) exhibit protumorigenic characteristics.
• These cells release tumor-supportive cytokines and express immunosuppressive molecules like programmed cell death 1 ligand 1 (PD-L1).

Purpose of the Study:

• To investigate the mechanism by which tumor cell-derived exosomes drive protumorigenic skewing in monocytes within the CLL microenvironment.
• To identify specific exosomal components responsible for modulating monocyte function.

Main Methods:

• RNA sequencing and proteome analysis of exosomes isolated from CLL patient plasma.
• Co-culture experiments with CLL-derived exosomes or purified hY4 RNA and monocytes (wild-type and Toll-like receptor 7-deficient).
• In vitro and in vivo studies assessing the impact of endosomal Toll-like receptor (TLR) signaling inhibition on monocyte activation and CLL development.

Main Results:

• Noncoding Y RNA hY4 was identified as a highly abundant RNA species enriched in exosomes from CLL patients.
• Transfer of CLL exosomes or hY4 induced CLL-associated monocyte phenotypes, including cytokine release (CCL2, CCL4, IL-6) and PD-L1 expression.
• These effects were dependent on Toll-like receptor 7 (TLR7) signaling, and inhibition of endosomal TLR signaling attenuated monocyte activation and CLL progression.

Conclusions:

• Exosome-mediated transfer of noncoding RNA hY4 contributes to cancer-related inflammation in CLL.
• This process facilitates immune escape through PD-L1 upregulation on monocytes.
• Targeting exosomal noncoding RNAs and endosomal TLR signaling presents a potential therapeutic strategy for CLL.